Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2009-12-15 Share Issue/Capital Cha…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the class, number, terms, and purpose of securities issued, specifically ordinary shares and options under employee plans. The document includes sections on quotation of securities and warranties to ASX. It is a formal announcement of new securities issued and their application for quotation on the ASX, consistent with regulatory filing requirements for capital changes. There are no financial statements or management discussion, nor is it a report or presentation. The content matches the definition of a Share Issue/Capital Change announcement, which covers new share issues and capital structure changes.
2009-12-15 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and remaining shares to be bought back. It also includes a compliance statement signed by the company secretary. The document is a regulatory form specifically reporting share repurchase activity. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document length is under 5,000 characters and contains substantive data about the buy-back, so it is not merely an announcement but the actual report. Therefore, the correct classification is POS with high confidence.
2009-12-14 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, total consideration paid, highest and lowest prices paid, and remaining shares to be bought back. It also includes a compliance statement signed by the company secretary. The content clearly relates to the company's repurchase of its own shares, which fits the category of a report on transactions in own shares. The document length is 4094 characters, which is consistent with a detailed notice rather than a brief announcement. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2009-12-13 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, total consideration paid, prices paid, and compliance statements. It is a regulatory form specifically reporting on the company's transactions in its own shares. The content is focused on share repurchase activity rather than financial results, management changes, or other report types. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is about 4,136 characters, which is sufficient to contain substantive data rather than just an announcement. Hence, the classification is POS with high confidence.
2009-12-10 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, total consideration paid, highest and lowest prices paid, and remaining shares to be bought back. It also includes a compliance statement signed by the company secretary. The content is focused on reporting the daily status of the company's share repurchase program, which aligns with the definition of a 'Transaction in Own Shares' filing. The document length is 4092 characters, which is relatively short but contains substantive data about the buy-back, not just an announcement or reference to a report. Therefore, it is not a report publication announcement or regulatory filing. The document is not an annual or interim report, nor a capital/financing update in the broader sense, but specifically a report on share repurchase activity.
2009-12-09 English
CSL R and D Briefing 72 pages ?Kb
Regulatory Filings
2009-12-09 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.